March 28, 2025 - 10:56

Financial services companies are still in the early stages of deploying generative and agentic artificial intelligence (AI), despite the growing discussions surrounding its potential. A recent roundtable hosted by the SEC highlighted the industry's cautious approach to integrating AI technologies. While the promise of AI in enhancing efficiency, risk management, and customer service is enticing, many firms are grappling with the practical challenges of implementation.
Regulatory concerns and the need for robust risk management frameworks are significant factors influencing this cautious stance. Participants at the roundtable expressed that while AI can transform operations, it also raises issues related to compliance, data privacy, and ethical considerations. The need for transparency in AI decision-making processes was emphasized, as stakeholders seek to ensure that AI systems are fair and accountable.
As financial institutions navigate these complexities, the focus remains on balancing innovation with regulatory obligations, aiming to harness AI's capabilities while safeguarding consumer interests and maintaining market stability.
September 12, 2026 - 00:50
US Tariff Refunds Slow as Government Collects More Than It Pays OutThe flow of tariff refunds from the US government has slowed sharply, with new figures showing the Treasury took in more money from tariffs than it returned to importers for the first time in...
September 11, 2026 - 02:46
Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another StoryRayonier Advanced Materials reported second-quarter results on August 4 for the period ending June 27, showing a mixed picture of financial performance. Net sales reached $376 million, an 18...
September 10, 2026 - 21:54
OpenAI Rolls Out ChatGPT for Financial Services With Major Industry PartnersOpenAI has introduced a version of ChatGPT built specifically for the financial sector, teaming up with several large brokerages and research organizations, including Morgan Stanley and S&P. The...
September 10, 2026 - 04:58
InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate UpdateVancouver-based InMed Pharmaceuticals has released its financial results for the full fiscal year that ended on June 30, 2026, alongside a broader update on its corporate activities. The company,...